Lion Point Capital, LP - MILESTONE PHARMACEUTICALS IN ownership

MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 49 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 4.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lion Point Capital, LP ownership history of MILESTONE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,395,642
+8.8%
450,2070.0%0.62%
+7.2%
Q2 2023$1,283,090
-23.4%
450,207
+5.9%
0.58%
-15.9%
Q1 2023$1,675,316
-42.1%
425,2070.0%0.69%
+67.5%
Q4 2022$2,893,000
-74.1%
425,207
-72.7%
0.41%
-83.3%
Q3 2022$11,186,000
+98.5%
1,557,233
+64.2%
2.46%
+284.6%
Q2 2022$5,634,000
+28.4%
948,570
+38.8%
0.64%
-37.0%
Q1 2022$4,388,000683,5701.02%
Other shareholders
MILESTONE PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
VHCP Management III, LLC 2,066,529$38,541,00023.79%
Novo Holdings A/S 2,674,470$49,879,0008.54%
ACUTA CAPITAL PARTNERS, LLC 369,500$6,891,0004.97%
RTW INVESTMENTS, LP 3,521,856$63,819,0003.80%
Boxer Capital, LLC 1,102,194$20,556,0001.49%
Ghost Tree Capital, LLC 235,000$4,383,0001.12%
VHCP Management II, LLC 148,560$2,771,0001.06%
Tekla Capital Management LLC 46,940$812,0000.04%
Baker Brothers Advisors 266,667$4,973,0000.03%
Zimmer Partners, LP 160,000$2,984,0000.03%
View complete list of MILESTONE PHARMACEUTICALS IN shareholders